Trial	Patients' characteristics	Ischaemic heart disease (%)	Treatment	Cardiovascular mortality		Follow up (years)
Treatment (%)	Placebo (%)
CONSENSUS	NYHA IV (cardiomegaly)	73	Enalapril	38	54	1
SOLVD-P	Asymptomatic (EF <35%)	83	Enalapril	13	14	4
SOLVD-T	Symptomatic (EF <35%)	71	Enalapril	31	36	4
SAVE	Postmyocardial infarction (EF <40%)	100	Captopril	17	21	4
V-HeFT I	NYHA II-III (EF <45%)	44	H-ISDN	37	41	5
V-HeFT II	NYHA II-III (EF <45%)	52	Enalapril	28	34*	5
PRAISE	NYHA III-IV (EF <30%)	63	Amlodipine	28	33	1.2